The global veterinary reference laboratory market is projected to grow from USD 6.12 billion in 2025 to USD 13.93 billion by 2035, driven by rising pet ownership, pet humanization trends, and increased demand for advanced diagnostics. However, high infrastructure costs and shortage of skilled specialists pose challenges to market expansion.

Zoetis reported Q4 2025 adjusted EPS of $1.48, beating consensus of $1.40, with sales of $2.387 billion up 3% YoY. However, key segments including dermatology, parasiticides, and osteoarthritis pain products (Librela/Solensia) showed declining growth. The company provided 2026 EPS guidance of $7.00-$7.10 above Street expectations, but analysts question the pathway to growth given competitive pressures and slowing key segments.

Zoetis is set to report Q4 2025 earnings on Feb. 12 after disappointing guidance last quarter caused an 11% stock decline. While the company has beaten earnings in four consecutive quarters and lowered expectations could set up positive surprises, investors remain concerned about persistent macro headwinds affecting its livestock business and osteoarthritis treatments. The analyst recommends long-term investors wait until after earnings to enter a position, as further downside risk exists if guidance disappoints again.

The global canine vaccines market is projected to grow from USD 2.05 billion in 2025 to USD 3.45 billion by 2033, with a CAGR of 6.79%. Growth is driven by rising pet ownership, increased awareness of preventive animal healthcare, and higher veterinary spending. Core vaccines and rabies vaccines lead by market share, while combination vaccines and Lyme disease vaccines show the fastest growth. North America dominates with 36.5% market share, while Asia Pacific is expected to grow fastest at 8.22% CAGR.

The global diesel generator market is projected to grow at a CAGR of 5.28% from 2026 to 2032, reaching USD 27.42 billion by 2032 from USD 18.17 billion in 2024. Growth is driven by industrialization, infrastructure development, rising power outages, and data center expansion. However, the market faces headwinds from stringent environmental regulations, high operational costs, and the shift toward renewable energy solutions.

The article highlights two dividend stocks, AbbVie and Zoetis, as excellent long-term investment options due to their stable business models, consistent revenue generation, and impressive dividend growth track records.

The global companion animal health market is projected to grow from USD 25.28 billion in 2024 to USD 61.74 billion by 2034, driven by rising pet ownership, pet humanization trends, and advances in veterinary technologies.

The global pet cancer therapeutics market is projected to grow from $493 million in 2025 to $1.15 billion by 2034, driven by increasing pet cancer awareness, advanced veterinary treatments, and growing pet humanization trends.

The article discusses two dividend stocks with strong long-term potential: Mastercard and Zoetis. Both companies demonstrate consistent growth, strong market positioning, and impressive dividend increase histories.

The article highlights two healthcare stocks with potential growth: Zoetis, a pet healthcare company facing temporary sales challenges, and UFP Technologies, a medical device contract manufacturer with strong acquisition and expansion strategies.

The veterinary oncology market is projected to grow from $1.84 billion in 2025 to $3.55 billion by 2030, driven by technological advances, rising pet ownership, and increasing demand for advanced cancer treatments in veterinary medicine.

The global veterinary artificial insemination market is projected to grow from USD 6.83 billion in 2024 to USD 12.15 billion by 2032, driven by advancements in reproductive technologies, genetic improvement initiatives, and sustainable livestock practices.